Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis

Visual deficits are among the most prevalent symptoms in patients with multiple sclerosis (MS). To understand deficits in the visual pathway during MS and potential treatment effects, we used experimental autoimmune encephalomyelitis (EAE), the most commonly used animal model of MS. The afferent vis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekyi, Maria T., Lauderdale, Kelli, Atkinson, Kelley C., Golestany, Batis, Karim, Hawra, Feri, Micah, Soto, Joselyn S., Diaz, Cobi, Kim, Sung Hoon, Cilluffo, Marianne, Nusinowitz, Steven, Katzenellenbogen, John A., Tiwari‐Woodruff, Seema K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018057/
https://www.ncbi.nlm.nih.gov/pubmed/33368801
http://dx.doi.org/10.1111/bpa.12930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018057/
https://www.ncbi.nlm.nih.gov/pubmed/33368801
http://dx.doi.org/10.1111/bpa.12930

Ejemplares similares